1. Cytokine Inhibition in Patients With Chronic Fatigue Syndrome
- Author
-
Jos W. M. van der Meer and Megan E. Roerink
- Subjects
musculoskeletal diseases ,0301 basic medicine ,medicine.medical_specialty ,medicine.medical_treatment ,lnfectious Diseases and Global Health Radboud Institute for Molecular Life Sciences [Radboudumc 4] ,030204 cardiovascular system & hematology ,Gastroenterology ,law.invention ,Pathogenesis ,03 medical and health sciences ,0302 clinical medicine ,Randomized controlled trial ,law ,Internal medicine ,Internal Medicine ,medicine ,Chronic fatigue syndrome ,Humans ,Outpatient clinic ,Adverse effect ,Fatigue ,Anakinra ,Fatigue Syndrome, Chronic ,business.industry ,Antagonist ,General Medicine ,medicine.disease ,030104 developmental biology ,Cytokine ,Immunology ,Cytokines ,business ,medicine.drug - Abstract
Few proven effective treatments exist for chronic fatigue syndrome (CFS). This randomized controlled trial evaluated the benefits and harms of anakinra, an interleukin-1–receptor antagonist, for wo...
- Published
- 2017